The decision, announced April 22, 2013, applies to any person or entity working in concert with Nutra Pure LLC. The Court further ordered Nutra Pure, LLC to transfer all of its internet domains incorporating the Satiereal name to INO'Réal. Nutra Pure also entered into a settlement agreement with INO'Réal, the terms of which are confidential.
“We are pleased that the United States District Court issued this judgment,” said Cedric Bourges,the CEO of INO'Réal. “We have spent the past decade developing Satiereal, and we are committed to defending the product and supporting our valued customers.
“The number of satisfied consumers using Satiereal continues to grow every day and we want them to be assured that they are purchasing the real thing, not a knock-off product without the clinically studied benefits of Satiereal.”
The ingredient is patented in Australia, Canada, and France for the use of saffron, the saffron extracts crocin and picrocrocin, and derivatives of these as a satiety agent in support of a healthy weight, while US patents are “anticipated in the near future”, said the company.